Agentix Corp. (AGTX): Operating Income
-$445.2K
Year ended 2026-03-31
-$340.3K
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$445.2K | n/m | 2026-07-01, From 2025-04-01 |
| 2025-03-31 | -$513.3K | n/m | 2026-07-01, From 2024-04-01 |
| 2024-03-31 | -$744.8K | n/m | 2025-07-16, From 2023-04-01 |
| 2023-03-31 | -$1.37M | n/m | 2024-08-30, From 2022-04-01 |
| 2022-03-31 | -$2.63M | n/a | 2023-07-14, From 2021-04-01 |
| No annual figure between 2019-08-31 and 2022-03-31. | |||
| 2019-08-31 | -$121.3K | n/m | 2019-12-05, From 2018-09-01 |
| 2018-08-31 | -$134.4K | n/m | 2019-12-05, From 2017-09-01 |
| 2017-08-31 | -$334.0K | n/m | 2018-11-13, From 2016-09-01 |
| 2016-08-31 | -$292.4K | n/c | 2017-12-18, From 2015-09-01 |
| 2015-08-31 | -$175.1K | n/m | 2016-12-12, From 2014-09-01 |
| 2014-08-31 | -$208.9K | n/a | 2015-12-16, From 2013-09-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Agentix Corp. (AGTX) | 2026-03-31 | -$445.2K | n/m |
| Mosaic ImmunoEngineering Inc. (CPMV) | 2025-12-31 | -$616.1K | n/m |
| Liminatus Pharma, Inc. (LIMN) | 2025-12-31 | -$2.97M | n/m |
| Adaptin Bio, Inc. (APTN) | 2025-12-31 | -$5.41M | n/m |
| Brainstorm Cell Therapeutics Inc. (BCLI) | 2025-12-31 | -$9.95M | n/m |
| Abpro Holdings, Inc. (ABPO) | 2025-12-31 | -$8.45M | n/m |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | -$5.39M | n/m |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | -$13.36M | n/m |
| Estrella Immunopharma, Inc. (ESLA) | 2025-12-31 | -$13.06M | n/a |
Compare AGTX, CPMV, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗